D. Demir Et Al. , "Outpatient radioiodine therapy for thyroid cancer: The evaluation of urine activity, bone marrow absorbed dose and dose rate from patients," 25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Milan, Italy, 2012
Demir, D. Et Al. 2012. Outpatient radioiodine therapy for thyroid cancer: The evaluation of urine activity, bone marrow absorbed dose and dose rate from patients. 25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , (Milan, Italy).
Demir, D., Demir, M., Gultekin, Y., Cavdar, C., Erees, S., Seyis, E., ... Sayman, H.(2012). Outpatient radioiodine therapy for thyroid cancer: The evaluation of urine activity, bone marrow absorbed dose and dose rate from patients . 25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, Italy
Demir, Demir Et Al. "Outpatient radioiodine therapy for thyroid cancer: The evaluation of urine activity, bone marrow absorbed dose and dose rate from patients," 25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, Italy, 2012
Demir, Demir Et Al. "Outpatient radioiodine therapy for thyroid cancer: The evaluation of urine activity, bone marrow absorbed dose and dose rate from patients." 25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Milan, Italy, 2012
Demir, D. Et Al. (2012) . "Outpatient radioiodine therapy for thyroid cancer: The evaluation of urine activity, bone marrow absorbed dose and dose rate from patients." 25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Milan, Italy.
@conferencepaper{conferencepaper, author={Demir Demir Et Al. }, title={Outpatient radioiodine therapy for thyroid cancer: The evaluation of urine activity, bone marrow absorbed dose and dose rate from patients}, congress name={25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)}, city={Milan}, country={Italy}, year={2012}}